Shares of Mylan (MYL -1.4%) reverse course and trade lower after an initial pop at the open on better than expected Q4 earnings. Revenue for the pharmaceutical maker jumped 7% Y/Y on better margins and an absence of litigation charges and acquisition related costs from the previous year ago period.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 1:30PM)
at Zacks.com (Fri, 8:33AM)
at Investor's Business Daily (Tue, 2:59PM)
at Investor's Business Daily (Mon, 2:59PM)
at Investor's Business Daily (Feb 2, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs